Consultation: long-term azithromycin in respiratory disease
Following development in Bury and adaptation for implementation across the ICB, we now seek comments on draft guidance for long-term azithromycin for chronic respiratory conditions.
All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.
- The messages sent from this form are transmitted via our host’s web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to email@example.com.
- This consultation closes at 5pm on Wednesday 7th June 2023.
|Document Title||Issue Date||Review Date||Status|
|Long-term azithromycin in chronic respiratory disease: guidance||20230402 Apr 2023||20230602 Jun 2023||Draft for consultation|